Skip to main content
Reply to N.-K.V. Cheung et al.
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.
Cytogenetic prognostication within medulloblastoma subgroups.
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.
Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors.
Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.